Potassium Chloride Capsule, · 23 active FDA presentation rows for this drug
Brand: POTASSIUM CHLORIDE
FDA lists Potassium Chloride Capsule, as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).
No availability text on this FDA row.
Potassium Chloride Capsule, Extended Release: To Be Discontinued
FDA availability text is not recorded on this row. 23 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Potassium Chloride Capsule, Extended Release
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Capsule, Extended Release
- Presentation
- Potassium Chloride, Capsule, Extended Release, 750 mg (NDC 62037-560-05)
- Package NDC
- 62037-560-05
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- May 19, 2025
- Last Updated
- May 19, 2025
- Therapeutic Category
- Endocrinology/Metabolism, Gastroenterology
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
potassium chloride
Side effects, interactions, warnings & more
Nearby, Other Potassium Shortage Records
Potassium Chloride Tablet, Extended Release
Teva Pharmaceuticals USA, Inc.
Tablet
Potassium Chloride Tablet, Extended Release
Teva Pharmaceuticals USA, Inc.
Tablet
Potassium Chloride Tablet, Extended Release
Teva Pharmaceuticals USA, Inc.
Tablet
Potassium Chloride Tablet, Extended Release
Teva Pharmaceuticals USA, Inc.
Tablet
Potassium Chloride Tablet, Extended Release
Upsher-Smith Laboratories, LLC
Tablet
Potassium Chloride Tablet, Extended Release
Upsher-Smith Laboratories, LLC
Tablet